Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators (Q74376597)
Jump to navigation
Jump to search
scientific article published on 01 March 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators |
scientific article published on 01 March 1998 |
Statements
Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators (English)
E J Topol
1 reference
D J Kereiakes
R M Califf
D P Miller
J E Tcheng
C F Cabot
K M Anderson
1 March 1998